Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
Date:2/29/2008

illion driven by increased sales of Megace(R) ES and fees related to the co-promotion of Androgel(R). Revenues from the Company's generic segment grew 1.3% to $684.9 million, as gains from 2007 launches were essentially offset by competitive pressures that adversely affected the volume and pricing of certain existing products. The third quarter 2007 launch of three additional strengths of metoprolol succinate ER (50mg, 100mg, and 200mg), coupled with the fourth quarter 2006 launch of the 25mg strength, drove $141.9 million of sales and $133.6 million of year-over- year gains. Par markets metoprolol in the U.S. through supply and distribution agreements with AstraZeneca Plc. In addition, the first quarter 2007 introductions of propranolol HCl extended release (ER) capsules and ranitidine HCl syrup benefited the full year by $57.5 million and $12.2 million, respectively. Products which experienced significant volume and pricing declines included fluticasone, various amoxicillin products, quinapril, cefprozil, tramadol HCl and acetaminophen tablets, lovastatin, and paroxetine.

Par's 2007 gross margin represented 34.9% of total revenues, an increase of 4.8 points from 30.1% in 2006, driven by increased contribution of higher margin revenues from Strativa, the branded division, including Megace(R) ES and co-promotion fees for Androgel(R). Revenues from Strativa represented 11.0% of total revenues, as compared to 6.8% in 2007. Gross margin also benefited from gains in the Company's generic division, principally reflective of the launch of higher margin propranolol HCl, lower inventory write-offs, lower sales of lower margin existing products, including fluticasone, and royalties earned from the sales of ondansetron tablets. These gains were somewhat tempered by increased metoprolol succinate ER sales, which have significantly lower gross margins than many of the other products sold by the Company.

Research and development (R&D) expense rose 24.4% from the ye
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
2. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
5. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
6. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
7. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
8. Lotus Pharmaceuticals Raises $5 Million in Private Placement
9. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... (PRWEB) June 01, 2015 June 1, ... of clinical journals in the areas of hospital medicine, ... announce that it has expanded upon its partnership with ... Hospital Medicine Practice, in a mobile application format ... tablets. , “We are very excited about the ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 InstantLabs will ... test as part of a Cooperative Research and Development ... (FDA). In accordance with U.S. Farm Bill legislation, ... marketed as catfish within the United States. , ... hours at the point-of need rather than requiring samples ...
(Date:6/1/2015)... 01, 2015 Good360 announced today ... Irene W. and C.B. Pennington Foundation, Louisiana’s largest ... of directors. Bertman joins Good360 just before the ... summer. , "Bringing with her many years of ... thrilled that Lori is joining the Good360 Board ...
(Date:6/1/2015)... June 01, 2015 "I was thinking of ... condom in a hands-free manner," said an inventor from La ... a condom on easier for beginners." , He developed the ... to put on a condom. The unit prevents the condom ... whenever they are needed. This promotes safe sex. The device ...
(Date:6/1/2015)... May, June and July shine a ... “National Barbecue Month”, and barbecue restaurants which are heavily ... Blue at 4150 Chain Bridge Road in Fairfax, ... spring and the pace follows into summer months. , ... seats inside and 35 seats outdoor on the patio ...
Breaking Medicine News(10 mins):Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4Health News:Lori Bertman Joins Good360 Board of Directors 2Health News:Red Hot & Blue Barbecue Restaurants Serve The Community 2Health News:Red Hot & Blue Barbecue Restaurants Serve The Community 3Health News:Red Hot & Blue Barbecue Restaurants Serve The Community 4
... Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies (December ... ... Horsham, PA (Vocus) October 28, 2008 -- The field of ... clinical trial safety and post-marketing pharmacovigilance becoming ever more critical ...
... TheHealthQuote, an online insurance provider, recently added "Protective Life Insurance ... ... Irvine, CA (PRWEB) October 28, 2008 ... Life Insurance Company to their current portfolio of top rated ...
... the sedative propofol may be at high risk for ... 2008, the 74th annual international scientific assembly of the ... use of propofol as an antiepileptic agent in patients ... not respond to initial treatment, was associated with significant ...
... October 28, 2008 Childhood obesity can lead to ... distress. Obese children and youth are likely to be ... pressure and stroke and incur higher healthcare costs. In ... the American Journal of Preventive Medicine, researchers ...
... Oct. 27 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ... annual,BIO Investor Forum on Thursday, October 30, 2008 at ... in San Francisco, California., Steve Worland, Ph.D., President ... of Anadys and an update on its development,programs., ...
... ARBOR, Mich., Oct. 27 Parrish Medical Center, ... Clinical,Xpert CareFocus(TM) and Clinical Xpert Navigator which are ... solutions from the Healthcare business of,Thomson Reuters., ... a hospital and give clinicians access to comprehensive ...
Cached Medicine News:Health News:DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks 2Health News:DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks 3Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 2Health News:Esteemed Medical and Life Insurance Provider Adds to Their List of Top-Rated Insurance Options 3Health News:Anti-seizure drug could be fatal 2Health News:Green neighborhoods may reduce childhood obesity 2Health News:Anadys Pharmaceuticals to Present at Bio Investor Forum 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 3
(Date:6/1/2015)... NEW YORK , June 1, 2015 ... devices distribute body weight over large area and improve ... pain and pressure ulcer. These devices play a significant ... ulcer. They help reduce the need to turn or ... Pressure relief devices include mattress, mattresses overlay, and specialty ...
(Date:6/1/2015)... -- NEOVIA ONCOLOGY Ltd. http://www.neoviaoncology.com/ a ... commercialization of novel, multi-function drugs for overcoming drug-resistant ... U.S. Food and Drug Administration (FDA) to discuss ... Drug (IND) application for its lead compound NEV-801. ... Neovia has clarified details of the development path ...
(Date:6/1/2015)...  AbbVie (NYSE: ABBV ) will participate in ... 2015. Richard A. Gonzalez , chairman and chief ... session at 8:30 a.m. Central time. A ... through AbbVie,s Investor Relations Web site at www.abbvieinvestor.com ... available later that day. About AbbVie ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Neovia Oncology Announces First IND Meeting 2
... 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , ... announced that,the two-year data from its European ... ("Vascular Wrap(TM)"),will be presented today at a ... the safety and efficacy of the Vascular,Wrap(TM) ...
... cord and other central,nervous system transplants possible, BOSTON, ... Eye Research Institute, an affiliate of Harvard Medical,School, ... into the adult central nervous system. The,study found ... induced by,stem cells) has the ability to break ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
... erythrocyte sedimentation rate analysers, which are ... generation unites the well-established advantages of ... of additional innovations which guarantee time-saving ... rate. Cost effectiveness is an essential ...
Blood sedimentation rate analysis...
... provides speed and precision in a ... Sysmex technology. With its advanced ... up to 300 samples or 500 ... This high performance, fully automated ...
... The Qwik-Let® Premier is our ... all the attributes of the ... the patented Lan-X feature. The ... safety and protection in the ...
Medicine Products: